154 related articles for article (PubMed ID: 3615345)
1. Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behaviour and catalepsy in rats: behavioural profile comparisons between raclopride, haloperidol and preclamol.
Hillegaart V; Ahlenius S
Pharmacol Toxicol; 1987 May; 60(5):350-4. PubMed ID: 3615345
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy.
Wadenberg ML; Ahlenius S
J Neural Transm Gen Sect; 1991; 83(1-2):43-53. PubMed ID: 1673344
[TBL] [Abstract][Full Text] [Related]
3. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
[TBL] [Abstract][Full Text] [Related]
4. PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects.
Corbin AE; Meltzer LT; Ninteman FW; Wiley JN; Christoffersen CL; Wustrow DJ; Wise LD; Pugsley TA; Heffner TG
Neuropharmacology; 2000 Apr; 39(7):1211-21. PubMed ID: 10760363
[TBL] [Abstract][Full Text] [Related]
5. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
Ogren SO; Hall H; Köhler C; Magnusson O; Sjöstrand SE
Psychopharmacology (Berl); 1986; 90(3):287-94. PubMed ID: 2947255
[TBL] [Abstract][Full Text] [Related]
6. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
Wadenberg MG; Browning JL; Young KA; Hicks PB
Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
[TBL] [Abstract][Full Text] [Related]
7. Effects of raclopride and haloperidol on spontaneous motor activity and on conditioned avoidance behavior in rats. A comparison of potency, efficacy and time-course of action.
Wadenberg ML; Ahlenius S
Arzneimittelforschung; 1991 Jul; 41(7):692-5. PubMed ID: 1772455
[TBL] [Abstract][Full Text] [Related]
8. Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: potential treatment of extrapyramidal side effects.
Svensson K; Eriksson E; Carlsson A
Neuropharmacology; 1993 Oct; 32(10):1037-45. PubMed ID: 7905192
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
Lublin H; Gerlach J; Peacock L
Psychopharmacology (Berl); 1993; 112(2-3):389-97. PubMed ID: 7871047
[TBL] [Abstract][Full Text] [Related]
10. Increased duration of dopamine receptor antagonist-induced effects on both behaviour and striatal dopamine turnover by repeated testing in rats.
Hillegaart V; Ahlenius S; Fowler CJ; Magnusson O
Pharmacol Toxicol; 1988 Aug; 63(2):114-7. PubMed ID: 3186617
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.
Wadenberg ML; Kapur S; Soliman A; Jones C; Vaccarino F
Psychopharmacology (Berl); 2000 Jul; 150(4):422-9. PubMed ID: 10958084
[TBL] [Abstract][Full Text] [Related]
12. Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission.
Ahlenius S; Hillegaart V
Pharmacol Biochem Behav; 1986 May; 24(5):1409-15. PubMed ID: 2873588
[TBL] [Abstract][Full Text] [Related]
13. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
Clark D; Furmidge LJ; Petry N; Tong ZY; Ericsson M; Johnson D
Psychopharmacology (Berl); 1991; 105(3):381-92. PubMed ID: 1686815
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.
Wadenberg ML; Salmi P; Jimenez P; Svensson T; Ahlenius S
Eur Neuropsychopharmacol; 1996 Nov; 6(4):305-10. PubMed ID: 8985714
[TBL] [Abstract][Full Text] [Related]
15. D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
Marin C; Parashos SA; Kapitzoglou-Logothetis V; Peppe A; Chase TN
Pharmacol Biochem Behav; 1993 May; 45(1):195-200. PubMed ID: 8516358
[TBL] [Abstract][Full Text] [Related]
16. The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat.
Clark D; Carlsson A; Hjorth S; Engel J; Lindberg P
Psychopharmacology (Berl); 1983; 81(1):14-7. PubMed ID: 6138790
[TBL] [Abstract][Full Text] [Related]
17. EFFECTS OF VERAPAMIL ON DOPAMINE DEPENDENT BEHAVIOURS IN RATS.
Malekar AR; Balsara JJ; Gaonkar RK
Indian J Physiol Pharmacol; 1999 Jan; 43(1):44-52. PubMed ID: 27093735
[TBL] [Abstract][Full Text] [Related]
18. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.
Anderson JJ; Randall S; Chase TN
J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756
[TBL] [Abstract][Full Text] [Related]
19. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
Wardas J; Pietraszek M; Ossowska K; Wolfarth S
Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
[TBL] [Abstract][Full Text] [Related]
20. The effects of haloperidol and raclopride in the paw test are influenced similarly by SCH 39166.
Prinssen EP; Ellenbroek BA; Stamatovic B; Cools AR
Eur J Pharmacol; 1993 Feb; 231(2):275-80. PubMed ID: 8095900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
